- Profile
- Personal Information
- Publications
Experts in Biochemistry
MOHAMMED SALMAN KHAN Biswadip Das Ekaterina M. Nestorovich Joel Caton Anil Roy Dubey Saheem Ahmad Sabrina Bhagwan Carole Ayoub Moubareck Dr.(Ms.) Neeloo Singh Sarah J. Ewing Ruchi Seth Kelly A. Grant Tobias Baskin Magdalena Bezanilla Jeffrey Blanchard Steven D. Brewer Samuel H.P. Chan Catherine Day Pamela L. Tuma Mark Banfield View MoreEdwin Moses began a successful commercial career at Amersham International, Enzymatix and Raggio-Italgene. From 1993-2001, first as CEO and later as Chairman, he was responsible for the growth of Oxford Asymmetry (OAI) through a series of venture rounds cumulating in a flotation (LSE) in 1998 at a value of £120 million. This was followed by a sale of the company to Evotec Biosystems in 2000 for £316 million. During this period, OAI grew from four people to over 250. Over the past fourteen years, Edwin has played an important role at Board level (primarily as Chairman) in over 15 European life science companies. During this time he has been involved in a number of financing rounds, a series of M&A transactions and four IPOs. He has been Chairman of Ablynx from 2004 till 2013, and in 2006 he was appointed Chief Executive Officer of the Company.
Biotechnology